Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs) Market | Size, Share, Growth

Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs) Market Research Report - Size, Share, Growth, and Trend Analysis | Forecast (2025 - 2030)

Published: 2025 - March

Report Code: VMR-18241

Region: Global

Request Sample

Customization

Ask an Expert

Enquire Enquire Before Buying

Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs) Market (2025-2030)

The Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs) Market encompasses the diagnosis, treatment, and management of a rare, heterogeneous group of tumors originating in the neuroendocrine cells of the gastrointestinal tract and pancreas. These tumors are classified into functional and non-functional types based on their hormonal activity, with therapeutic approaches spanning targeted therapies, somatostatin analogs, and radiopharmaceuticals.

Disruptive Impact and Opportunities:

GEP-NETs represent a rapidly evolving segment due to advancements in molecular diagnostics and precision therapies. Breakthrough treatments like radioligand therapies offer new approaches, redefining patient outcomes. Emerging administration methods and combination therapies provide easy integration into existing clinical pathways. Novel therapies demonstrate enhanced safety profiles (safe) compared to traditional cytotoxic agents. Expanding prevalence and unmet clinical needs in advanced stages create a big opportunity for stakeholders.

Emerging Drugs:

177Lu-edotreotide
CAM2029

Marketed Drugs:

Capecitabine (Xeloda)
5-fluorouracil (5-FU)
Doxorubicin (Adriamycin)

Key Companies:

Novartis
Ipsen Biopharmaceuticals
Pfizer
ITM Isotopen Technologien Muenchen
Camurus AB
Hutchison Medipharma Limited
Bristol-Myers Squibb
Eisai Limited
Experior S.L.
Tarveda Therapeutics
Roche Pharma

Market Segmentation:

By Type

Functional GEP-NETs
- Insulinomas
- Gastrinomas
- Glucagonomas
- Somatostatinomas
- VIPomas (Vasoactive Intestinal Peptide Tumors)
Non-Functional GEP-NETs

By Administration Type

Injectable
- Intravenous (IV)
- Subcutaneous (SC)
Oral

What’s in It for You?

Strategic Insights: Identify key trends, emerging therapies, and market disruptions.
Competitive Edge: Benchmark against industry leaders and emerging players.
Investment Opportunities: Explore high-growth segments and innovative therapies.
Market Entry Support: Gain actionable insights for effective go-to-market strategies.
Comprehensive Outlook: Understand the evolving landscape to make data-driven decisions.

Gastroenteropancreatic Neuroendocrine Tumors Gep Nets Market - Executive Summary
1. Introduction
2. Objectives
3. Key Findings
  1. Market Size 2025 & 2030: By Key Country (10MM)
  2. Global Market Size 2025 & 2030: By Key Segment
  3. Key Investments & Startup Analysis
4. Research Methodology
Understanding the Disease
1. Disease Overview
2. Classification
3. Signs and Symptoms
4. Risk Factors
5. Causes
6. Disease Biology & Digital Innovations
7. Stages & Staging System
8. Diagnostic Algorithm
9. Current Treatment Practices & Algorithm
10. Current Standard of Care and Treatment Gaps
11. Patient Demographics and Treatment Pathways
Guidelines
Unmet Needs
Epidemiology and Patient Population
1. Epidemiology Key Findings
2. Assumptions and Rationale: 10MM
3. Epidemiology Scenario: 10MM
4. U.S. Epidemiology Scenario
5. EU-5 Epidemiology
  1. U.K. Epidemiology Scenario
  2. Germany Epidemiology Scenario
  3. France Epidemiology Scenario
  4. Italy Epidemiology Scenario
  5. Spain Epidemiology Scenario
6. Japan Epidemiology Scenario
7. China Epidemiology Scenario
8. Australia Epidemiology Scenario
9. India Epidemiology Scenario
Real-world Data & Real-world Evidence
Drug Development Landscape
1. Existing Key Drug Candidate Profiles/ Marketed Therapies
2. Competitive Analysis and Differentiation
3. Overview of Similar/Competing Drugs in Clinical Trials
4. Future Trends and Emerging Drugs
Regulatory Strategy and Potential Challenges
1. Regulatory Pathways in Key Markets
2. Anticipated Regulatory Hurdles and Mitigation Strategies
3. Case Studies in Oncology Drug Regulation
4. Impact of Potential Changes to Regulatory Framework
Commercial Landscape
1. Market Size & Growth Rates
2. Key Approvals & Anticipated Loss of Exclusivity
3. PESTLE & Porter’s Five Forces Analysis
4. Market Shares, Positioning/Ranking
5. Market Drivers
6. Identification of Threats
7. Digital Evolution in Commercialization
Market Segmentation
Pricing, Reimbursement, and Access
1. Competitive Pricing Analysis
2. Reimbursement Landscape and Challenges
3. Strategies for Market Access and Equity
4. Patient Spending/Expenditure Analysis
Future Trends, Disruptions, and Opportunities
1. Analysis of Emerging Trends
2. Technological Impact
3. Impact of Potential Market Disruptors
4. Opportunities for Future Development and Expansion
5. Considerations for Investment Opportunities
Global Market Dynamics
1. Regional Regulatory Disparities
2. Cross-Border Partnership Strategies
3. Global Supply Chain Dynamics
4. Case Studies: Success and Failure in Global Markets
5. Strategies for Global Expansion and Localization
Company Profiles

Download Sample

Full Name *

Job Title *

Company *

Email *

Phone *

Country *

Message

↻

The field with (*) is required.

Choose License Type

Excel Data Pack

2500

Single User

4250

Multi User

5250

Corporate User

6900